VCAM1 and cancer: This work combines the VCAM-1 inhibitor Suc and the chemotherapeutic Dox in a well-designed nano-delivery system to suppress primary tumors and their lung metastases simultaneously, which provides a promising drug delivery strategy for the treatment of metastatic malignant tumors.